Soy isoflavones powder is a naturally occurring plant compound classified as phytoestrogen, primarily found in soybeans and soy-derived products. Due to their structural similarity to human estrogen, they have garnered significant interest for their potential health benefits and risks. This paper reviews the safety of soy isoflavones powder.
Chemical Nature and Sources of Soy Isoflavones
Chemicals of Soy Isoflavones
Soy isoflavones are polyphenolic compounds with a basic structure resembling 17β-estradiol. The major isoflavones in soy include genistein, daidzein, and glycitein. These compounds of soy isoflavones powder exist mostly as glycosides (bound to sugar moieties) in raw soy but are converted to aglycones in the gut, facilitating absorption.
Isoflavone Content in Soy Products
Soy isoflavones are naturally occurring compounds primarily found in soybeans (Glycine max) and soy-based products. They are the most significant dietary source of isoflavones for humans, especially in Asian diets where soy consumption is high. The isoflavones in soy include genistein, daidzein, and glycitein, and they are mainly present in the plant as glycosides (genistin, daidzin, and glycitin).
•Soybeans
Raw and whole soybeans contain the highest concentration of soy isoflavone. The content can vary depending on the soybean variety, cultivation conditions, and harvest time. On average, soybeans contain 1–4 mg of isoflavones per gram of dry weight.
•Soy Flour and Soy Protein Products
Defatted soy flour and textured soy protein are concentrated forms of soy used in various processed foods. These products retain much of the original isoflavone content. Soy protein isolate, a refined form of soy protein used in health foods and supplements, can contain up to 90 mg of isoflavones per 100 grams.
•Fermented Soy Foods
Fermented soy products like miso, natto, and tempeh are excellent sources of soy isoflavone powder in their aglycone form, which are more bioavailable. Fermentation breaks down glycosides into aglycones, making these foods nutritionally potent.
•Non-Fermented Soy Foods
Foods like tofu, soy milk, and edamame also contain significant levels of isoflavones, although in glycosidic form. For example, one cup of soy milk typically contains 20–30 mg of isoflavones.
References About the Safety of Soy Isoflavones
Hormone-Dependent Tissues and Cancer Risk
•Messina, M. summarizes extensive clinical and epidemiological data, concluding that soy isoflavones powder is generally safe and may have protective effects against breast and prostate cancers. It highlights that soy consumption during adolescence might confer long-term cancer risk reduction.[1]
•Duffy, C. J., & Amato, P. (2019). provides an in-depth analysis of observational studies and clinical trials examining the relationship between soy intake and breast cancer risk, finding no evidence of increased risk and some evidence of risk reduction. It addresses concerns about isoflavone supplements in breast cancer survivors.[2]
•Messina, M., & Barnes, S. (1991). reviewing soy isoflavones' estrogenic activity and their potential to reduce hormone-dependent cancers, suggesting no safety concerns at dietary levels.[3]
Thyroid Function and Soy Isoflavones
•Messina, M., Redmond, G. (2006). Review human studies evaluating soy isoflavones' impact on thyroid hormone synthesis and thyroid function, emphasizing that soy is safe for euthyroid individuals with sufficient iodine intake. Potential thyroid disruption is mainly a concern with iodine deficiency..[4]
•Godfrey, M., et al. (2013). shows no significant effect of soy isoflavones powder on thyroid function parameters in healthy adults, confirming safety in typical dietary exposure.[5]
Reproductive and Developmental Safety
•Cederroth, C. R., et al. (2012). Review examines animal and human data on reproductive outcomes after soy isoflavone exposure. It concludes that typical dietary levels do not impair fertility or reproductive development.[6]
•Setchell, K. D. R., & Cole, S. J. (2003). discusses metabolism differences influencing isoflavone effects but provides evidence that soy consumption is safe across different population groups, including infants.[7]
Safety in Infants and Children
Andres, A., et al. (2015). Review decades of clinical data on soy formula use in infants, concluding that soy-based infant formula is safe with no adverse effects on growth, development, or reproductive health.[8]
Dewell, A., et al. (2008). Finding no evidence that soy formula exposure in infancy causes hormonal or developmental harm.[9]
Regulatory Perspectives
European Union (EU) – EFSA
The European Food Safety Authority (EFSA) has conducted one of the most comprehensive evaluations of soy isoflavones powder safety. In 2015, EFSA published a scientific opinion assessing isoflavones from soy and red clover used in food supplements. EFSA concluded that:
Supplemental isoflavones (up to 150 mg/day) from soy are generally safe for postmenopausal women when used for up to 30 months.
No significant adverse effects on breast tissue, endometrium, or thyroid function were observed in the studied populations.
The agency did note the lack of long-term data for younger populations or high-risk groups, recommending further studies in those areas.
EFSA has not set a specific Acceptable Daily Intake (ADI), but soy isoflavones powder safety opinion effectively guides regulatory practices across the EU.
United States – FDA
The U.S. Food and Drug Administration (FDA) has not issued specific safety limits for soy isoflavones but has acknowledged their safety indirectly. In 1999, the FDA approved a qualified health claim stating that "25 grams of soy protein a day may reduce the risk of heart disease," suggesting soy foods-and by extension, soy isoflavones-are safe at typical dietary levels.
While the FDA has not formally evaluated soy isoflavones powder supplements, they are permitted under the Dietary Supplement Health and Education Act (DSHEA), provided manufacturers ensure product safety and proper labeling. Clinical data from U.S. sources support the safety of soy isoflavones for most populations, including infants consuming soy-based formulas.
Japan – FOSHU and Consumer Guidelines
Japan, where soy foods are dietary staples, has significant experience with soy isoflavones powder. The Japanese government has established guidelines for isoflavone supplements under the Foods for Specified Health Uses (FOSHU) system:
•Daily intake from supplements is limited to 30 mg/day, on top of average food intake.
•The Ministry of Health, Labour and Welfare (MHLW) recommends total daily intake (including food) not exceed 70–75 mg/day to minimize potential estrogenic risks.
Labels on pure soy isoflavones supplements must include cautionary statements, particularly for pregnant and lactating women.
Australia and New Zealand – FSANZ
Food Standards Australia New Zealand (FSANZ) considers soy isoflavones safe at levels naturally present in soy-based foods. For soy-based infant formulas, FSANZ and health agencies have determined no consistent evidence of adverse health outcomes. However, they recommend limiting soy formula use to medical indications when alternatives are available, as a precautionary approach.
Overall, scientific evidence strongly supports the safety of soy isoflavones powders consumed at dietary levels. While some concerns remain in special populations or at very high supplemental doses, current data do not indicate significant risks for the general population. Continued research and long-term studies will further clarify the safety profile.
Guanjie Biotech has focused on a wholesale soy isoflavones factory. We extract soy isoflavones powder from natural non-GMO soybean germ with the assay of 10%,20%,4% and 80%. Welcome to enquiry:info@gybiotech.com.
References:
[1]Messina, M. (2016). "Soy and health update: evaluation of the clinical and epidemiologic literature." Nutrients, 8(12), 754.
[2]Duffy, C. J., & Amato, P. (2019). "Soy isoflavones and breast cancer risk: a review of the literature." Journal of the National Cancer Institute, 111(7), 675-685.
[3]Messina, M., & Barnes, S. (1991). "The role of soy products in reducing the risk of cancer." Journal of the National Cancer Institute, 83(8), 541-546.
[4]Messina, M., Redmond, G. (2006). "Effects of soy protein and isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the literature." Thyroid, 16(3), 249-258.
[5]Godfrey, M., et al. (2013). "Soy isoflavones and thyroid function: systematic review and meta-analysis of randomized controlled trials." Thyroid, 23(9), 1167-1175.
[6]Cederroth, C. R., et al. (2012). "Soy, phytoestrogens and their effects on reproduction in humans and animals." Reproductive Toxicology, 33(2), 231-243.
[7]Setchell, K. D. R., & Cole, S. J. (2003). "Method of defining equol-producer status and its frequency among vegetarians." The Journal of Nutrition, 133(6), 1436-1441.
[8]Andres, A., et al. (2015). "Safety of soy-based infant formulas: a review." JAMA Pediatrics, 169(4), 389-393.
[9]Dewell, A., et al. (2008). "Isoflavone exposure in infants consuming soy formula: a review of the clinical evidence." Pediatric Clinics of North America, 55(2), 269-282.
